発表論文

Update 18-SEP-2018

*Corresponding author

2018

  1. Tsugawa H., Mori H., Matsuzaki J., Sato A., Saito Y., Imoto M., Suematsu M., *Suzuki H. CAPZA1 determines the risk of gastric carcinogenesis by inhibiting Helicobacter pylori CagA-degraded autophagy. Autophagy, in press. doi:10.1080/15548627.2018.1515530.
  2. Blay E. A., Kumagai T., Yamabe M., Hino A., Shimogawara R., Kim H.-S., Sato A., Ichimura K., Ayi I., Iwanaga S., *Ohta N. Insights into the mode of action of 1,2,6,7-tetraoxaspiro [7.11] nonadecane (N-89) against adult Schistosoma mansoni worms. Parasitology International, 67(4), 403-412, 2018. doi: 10.1016/j.parint.2018.03.006.
  3. Ogino Y., *Sato A., Uchiumi F., *Tanuma S. Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment. Oncotarget, 9(23), 16451-16461, 2018. doi: 10.18632/oncotarget.24731.
  4. El-Far A.H.A.M., Munesue S., Harashima A., Sato A., Shindo M., Nakajima S., Inada M., Tanaka M., Takeuchi A., Tsuchiya H., Yamamoto H., Shaheen H.M.E., EL-SAYED Y.S., Kawano S., Tanuma S., *Yamamoto Y. In vitro anticancer effects of a RAGE inhibitor discovered using a structure-based drug design system. Oncology Letters, 15, 4627-4634, 2018. doi: 10.3892/ol.2018.7902.

 

search previous next tag category expand menu location phone mail time cart zoom edit close